Ahmed-Khan Mohammad, Moin Kayvon, Funk Carly, Sachdev Mala, Jiffry Mohamed Zakee Mohamed
Danbury Hospital-Yale University, School of Medicine, Danbury, Netherlands Antilles.
American University of the Caribbean, School of Medicine, Cupecoy, Sint Maarten, Netherlands Antilles.
Arch Clin Cases. 2023 Mar 14;10(1):29-31. doi: 10.22551/2023.38.1001.10235. eCollection 2023.
Diffuse alveolar hemorrhage (DAH) is a potentially life-threatening pulmonary pathology which results in intra-alveolar hemorrhage secondary to disruption of the alveolar capillary basement membrane. Most commonly, these patients present with hemoptysis, hypoxemia and pulmonary infiltrates. Although rare, sevoflurane, an inhalational anesthetic used as a rapid induction agent for anesthesia may be implicated in the etiology of DAH. We report a case of a 21-year-old otherwise healthy male found to have postoperative diffuse alveolar hemorrhage secondary to sevoflurane inhalation. Thus far, only five documented cases describing sevoflurane induced diffuse alveolar hemorrhage have been described in the literature, with prior cases also showing a clear temporal association between sevoflurane administration and symptom onset. Although uncommon, we must take sevoflurane into consideration as a possible etiology of diffuse alveolar hemorrhage when encountering signs of respiratory distress and hemoptysis in postoperative patients.
弥漫性肺泡出血(DAH)是一种潜在的危及生命的肺部疾病,它导致肺泡毛细血管基底膜破坏后继发肺泡内出血。这些患者最常见的表现为咯血、低氧血症和肺部浸润。虽然罕见,但七氟烷,一种用作麻醉快速诱导剂的吸入性麻醉剂,可能与DAH的病因有关。我们报告一例21岁的健康男性,术后因吸入七氟烷继发弥漫性肺泡出血。迄今为止,文献中仅记载了5例描述七氟烷诱导弥漫性肺泡出血的病例,之前的病例也显示七氟烷给药与症状发作之间存在明显的时间关联。虽然不常见,但当术后患者出现呼吸窘迫和咯血迹象时,我们必须将七氟烷视为弥漫性肺泡出血的一种可能病因。